Delta-plus: is new mutation most infectious Covid-19 strain yet?
The Delta descendent already accounts for one in ten UK coronavirus cases
A descendent of the Delta coronavirus strain is being closely monitored by scientists who fear that the new variant may be more infectious than the original.
Experts say the AY.4.2 subvariant now accounts for almost 10% of all UK coronavirus cases and may be up to 15% more transmissible than the original Delta variant, currently the dominant strain of Covid worldwide.
Francois Balloux, director of the University College London (UCL) Genetics Institute, told the Financial Times (FT) that preliminary evidence suggested that the new Delta-plus strain may be the most infectious coronavirus variant yet in the global pandemic.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“But we have to be careful at this stage,” said Balloux. “Britain is the only country in which it has taken off in this way and I still would not rule out its growth being a chance demographic event.”
The subvariant is being monitored by the World Health Organization and could be assigned a Greek letter under the global body’s naming system if “elevated to the rank of ‘Variant under Investigation’”, he added.
Reports worldwide about the spread of the new subvariant in the UK has triggered concerns in countries including the US. The UK is seen as a “harbinger of things to come for other countries during the pandemic”, said CNBC. Some scientists have suggested that the new subvariant is a “possible factor” in the hike in case numbers in the UK over the past few months, the news site added.
On Sunday, former US Food and Drug Administration commissioner Scott Gottlieb tweeted: “We need urgent research to figure out if this delta plus is more transmissible, has partial immune evasion?”
The tally of new Covid cases in the UK reached 49,156 yesterday, the highest since 17 July. The total far outstrips those in many other European nations.
Monday’s tally is only “19,000 cases short of the peak number of cases ever recorded in the UK”, said The Guardian. The record figure of 68,053 cases was reached on 8 January, “at the height of the most devastating wave of the pandemic last winter”.
Research into the new subvariant is already under way. Jeffrey Barrett, director of the Covid-19 Genomics Initiative at the Wellcome Sanger Institute in Cambridge, told the FT that while the new variant “may make things more difficult”, the subtype “doesn’t by itself explain the recent high UK caseload”.
The subvariant contains two major spike protein mutations that “have been recorded individually in previous coronavirus lineage”, the paper reported. But why the spike protein mutations may make the AY.4.2 subvariant more infectious is unclear.
“They are not obvious candidates for immune escape, increased transmissibility or higher virulence,” said UCL expert Balloux.
Infectious disease specialist Peter Chin-Hong, from the University of California San Francisco, told the San Francisco Chronicle that the new subvariant was unlikely to be “stickier and more transmissible, make vaccines or monoclonal antibodies work less well, or cause people to become more sick”.
He explained that the two major spike protein mutations found in the new variant, A222V and Y145H, “aren’t in the place where the virus binds to the receptor”, meaning the virus is less effective at latching on to human cells.
All the same, he said, “it feels worthwhile keeping an eye on it”.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Band Aid 40: time to change the tune?
In the Spotlight Band Aid's massively popular 1984 hit raised around £8m for famine relief in Ethiopia and the charity has generated over £140m in total
By Rebekah Evans, The Week UK Published
-
Starmer vs the farmers: who will win?
Today's Big Question As farmers and rural groups descend on Westminster to protest at tax changes, parallels have been drawn with the miners' strike 40 years ago
By The Week UK Published
-
How secure are royal palaces?
The Explainer Royal family's safety is back in the spotlight after the latest security breach at Windsor
By Chas Newkey-Burden, The Week UK Published
-
What went wrong at CVS?
Today's Big Question Pharmacy chains are in crisis
By Joel Mathis, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published